Published in Neurosci Lett on February 20, 2003
Exogenously applied muscle metabolites synergistically evoke sensations of muscle fatigue and pain in human subjects. Exp Physiol (2013) 2.67
Muscle pain: mechanisms and clinical significance. Dtsch Arztebl Int (2008) 2.04
Dry needling - peripheral and central considerations. J Man Manip Ther (2011) 1.45
Cardiovascular regulation by skeletal muscle reflexes in health and disease. Am J Physiol Heart Circ Physiol (2011) 1.11
Purinergic 2 receptor blockade prevents the responses of group IV afferents to post-contraction circulatory occlusion. J Physiol (2006) 1.08
Algesic agents exciting muscle nociceptors. Exp Brain Res (2009) 0.94
Gadolinium inhibits group III but not group IV muscle afferent responses to dynamic exercise. J Physiol (2008) 0.94
Painful and non-painful pressure sensations from human skeletal muscle. Exp Brain Res (2004) 0.92
Contribution of nerve growth factor to upregulation of P2X₃ expression in DRG neurons of rats with femoral artery occlusion. Am J Physiol Heart Circ Physiol (2011) 0.92
Eccentric muscle contraction and stretching evoke mechanical hyperalgesia and modulate CGRP and P2X(3) expression in a functionally relevant manner. Pain (2010) 0.91
Purinergic 2X receptors play a role in evoking the exercise pressor reflex in rats with peripheral artery insufficiency. Am J Physiol Heart Circ Physiol (2013) 0.87
P2X2/3 and P2X3 receptors contribute to the metaboreceptor component of the exercise pressor reflex. J Appl Physiol (1985) (2010) 0.86
Fatigue-enhanced hyperalgesia in response to muscle insult: induction and development occur in a sex-dependent manner. Pain (2013) 0.85
Emerging peripheral receptor targets for deep-tissue craniofacial pain therapies. J Dent Res (2009) 0.84
The role of TRPA1 in muscle pain and mechanical hypersensitivity under inflammatory conditions in rats. Neuroscience (2015) 0.82
Repeated muscle injury as a presumptive trigger for chronic masticatory muscle pain. Pain Res Treat (2011) 0.81
Mechanisms of Myofascial Pain. Int Sch Res Notices (2014) 0.79
P2X₃ and TRPV1 functionally interact and mediate sensitization of trigeminal sensory neurons. Neuroscience (2012) 0.79
Optogenetic patterning of whisker-barrel cortical system in transgenic rat expressing channelrhodopsin-2. PLoS One (2014) 0.77
Anatomical and physiological factors contributing to chronic muscle pain. Curr Top Behav Neurosci (2014) 0.76
ATP-sensitive muscle afferents activate spinal trigeminal neurons with meningeal afferent input in rat - pathophysiological implications for tension-type headache. J Headache Pain (2016) 0.75
Effect of Intramuscular Protons, Lactate, and ATP on Muscle Hyperalgesia in Rats. PLoS One (2015) 0.75
T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol (2008) 5.44
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med (2005) 4.84
Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula. J Mol Med (Berl) (2006) 4.00
Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study. Circulation (2007) 3.59
Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation (2004) 2.64
A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res (2006) 2.50
Protective arms of the renin-angiotensin-system in neurological disease. Clin Exp Pharmacol Physiol (2013) 2.18
The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res (2007) 2.00
The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. J Hypertens (2008) 1.91
Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats. J Hypertens (2008) 1.81
Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press (2003) 1.79
Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol (2004) 1.75
Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation (2008) 1.72
PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension (2005) 1.60
Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity. Diabetes (2005) 1.58
Chronic treatment with losartan results in sufficient serum levels of the metabolite EXP3179 for PPARgamma activation. Hypertension (2009) 1.54
Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J (2005) 1.54
Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension (2010) 1.50
Angiotensin receptor blockers: therapeutic targets and cardiovascular protection. Blood Press (2005) 1.49
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens (2004) 1.48
Injection of nerve growth factor into a low back muscle induces long-lasting latent hypersensitivity in rat dorsal horn neurons. Pain (2013) 1.47
Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol (2003) 1.46
High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens (2004) 1.43
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis. J Hypertens (2014) 1.40
Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism. Diabetes (2007) 1.39
Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet (2008) 1.35
RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection. Clin Res Cardiol (2008) 1.34
Acidic pH and capsaicin activate mechanosensitive group IV muscle receptors in the rat. Pain (2004) 1.27
Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the rat. Pain (2005) 1.19
Non-peptide AT2-receptor agonists. Curr Opin Pharmacol (2010) 1.15
Cardiac c-kit+AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance. Stem Cells (2009) 1.15
Novel therapeutic targets for hypertension. Nat Rev Cardiol (2010) 1.13
Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertension. Hypertension (2011) 1.12
Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J Hypertens (2003) 1.11
Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients. Cardiovasc Diabetol (2007) 1.10
Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol (2010) 1.10
Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. FASEB J (2003) 1.10
AT2 receptor agonists: hypertension and beyond. Curr Opin Nephrol Hypertens (2012) 1.09
Identification of noncytotoxic and IL-10-producing CD8+AT2R+ T cell population in response to ischemic heart injury. J Immunol (2010) 1.08
Direct angiotensin II type 2 receptor stimulation in Nω-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling. Hypertension (2012) 1.07
Sex differences in physiological cardiac hypertrophy are associated with exercise-mediated changes in energy substrate availability. Am J Physiol Heart Circ Physiol (2011) 1.04
Genetic kininogen deficiency contributes to aortic aneurysm formation but not to atherosclerosis. Physiol Genomics (2004) 1.02
PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice. Cardiovasc Diabetol (2010) 1.02
Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan. Diabetes (2008) 1.01
The past, present and future of angiotensin II type 2 receptor stimulation. J Renin Angiotensin Aldosterone Syst (2009) 0.99
Sensitization of rat dorsal horn neurons by NGF-induced subthreshold potentials and low-frequency activation. A study employing intracellular recordings in vivo. Brain Res (2007) 0.99
Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren. J Hypertens (2008) 0.99
Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain. Brain Res (2008) 0.98
Angiotensin receptor blockers and cerebral protection in stroke. J Hypertens Suppl (2006) 0.97
The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Fundam Clin Pharmacol (2009) 0.96
Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats. J Hypertens (2002) 0.95
Pathophysiologic and therapeutic importance of tissue ACE: a consensus report. Cardiovasc Drugs Ther (2002) 0.94
AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression. Neurobiol Dis (2012) 0.93
Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin system. Cancer Res (2012) 0.93
Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components. Atherosclerosis (2009) 0.92
Painful and non-painful pressure sensations from human skeletal muscle. Exp Brain Res (2004) 0.92
Neuroprotection with angiotensin receptor antagonists: a review of the evidence and potential mechanisms. Am J Cardiovasc Drugs (2005) 0.91
Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation. J Hypertens (2008) 0.91
Experimental pain by ischaemic contractions compared with pain by intramuscular infusions of adenosine and hypertonic saline. Eur J Pain (2003) 0.91
Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation. J Neurochem (2005) 0.91
Dorsal horn neurons having input from low back structures in rats. Pain (2007) 0.90
The angiotensin AT2 receptor in left ventricular hypertrophy. J Hypertens (2010) 0.90
Endothelial dysfunction and its role in diabetic vascular disease. Endocrinol Metab Clin North Am (2006) 0.89
Aldosterone synthase inhibitors in cardiovascular and renal diseases. Nephrol Dial Transplant (2014) 0.89
Impact of the AT(2) receptor agonist C21 on blood pressure and beyond. Curr Hypertens Rep (2012) 0.89
Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells. J Neurochem (2003) 0.89
Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J Cereb Blood Flow Metab (2011) 0.88
AT(2) receptor and tissue injury: therapeutic implications. Curr Hypertens Rep (2014) 0.87
Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage. Hypertens Res (2009) 0.87
Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites. Hypertension (2005) 0.87
The possible role of the NO-cGMP pathway in nociception: different spinal and supraspinal action of enzyme blockers on rat dorsal horn neurones. Pain (2005) 0.87
Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome. J Mol Med (Berl) (2013) 0.86
Are angiotensin receptor blockers neuroprotective? Curr Hypertens Rep (2004) 0.86
Cardiovascular protection for all individuals at high risk: evidence-based best practice. Clin Res Cardiol (2008) 0.86
Role of spinal microglia in myositis-induced central sensitisation: an immunohistochemical and behavioural study in rats. Eur J Pain (2008) 0.85
Over-expression of angiotensin converting enzyme-1 augments cardiac hypertrophy in transgenic rats. Hum Mol Genet (2004) 0.85
The (pro)renin receptor ((P)RR) can act as a repressor of Wnt signalling. Biochem Pharmacol (2012) 0.85
Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats. Blood Press (2006) 0.85
Vasoactive peptides, their receptors and drug development. Basic Clin Pharmacol Toxicol (2004) 0.85
New therapeutic pathways in the RAS. J Renin Angiotensin Aldosterone Syst (2012) 0.85
The angiotensin AT2 receptor in inflammation. Drug News Perspect (2010) 0.85
Estrogen receptor alpha supports cardiomyocytes indirectly through post-infarct cardiac c-kit+ cells. J Mol Cell Cardiol (2009) 0.85
Low-dose lithium combined with captopril prevents stroke and improves survival in salt-loaded, stroke-prone spontaneously hypertensive rats. J Hypertens (2005) 0.85
Adapter proteins and promoter regulation of the angiotensin AT2 receptor--implications for cardiac pathophysiology. J Renin Angiotensin Aldosterone Syst (2009) 0.84
Key advances in antihypertensive treatment. Nat Rev Cardiol (2012) 0.84
Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease. Am Heart J (2013) 0.84
Nociceptive input from the rat thoracolumbar fascia to lumbar dorsal horn neurones. Eur J Pain (2011) 0.84
Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartan. Expert Rev Cardiovasc Ther (2006) 0.83
Neuroanatomical pathway of nociception originating in a low back muscle (multifidus) in the rat. Neurosci Lett (2007) 0.83
Cardiac PPARalpha expression in patients with dilated cardiomyopathy. Eur J Heart Fail (2005) 0.83